-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Revenues history and growth rate from Q1 2018 to Q3 2024.
- Vir Biotechnology, Inc. Revenues for the quarter ending September 30, 2024 was $2.38M, a 9.81% decline year-over-year.
- Vir Biotechnology, Inc. Revenues for the twelve months ending September 30, 2024 was $78.6M, a 33.8% decline year-over-year.
- Vir Biotechnology, Inc. annual Revenues for 2023 was $86.2M, a 94.7% decline from 2022.
- Vir Biotechnology, Inc. annual Revenues for 2022 was $1.62B, a 47.5% increase from 2021.
- Vir Biotechnology, Inc. annual Revenues for 2021 was $1.1B, a 1334% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)